Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

WW earnings analysis

Filed May 7, 2026 · Our reading of the company's report

The latest report

WW International reported Q1 2026 results with revenue of $168.3 million, down 9.6% from $185.2 million year-over-year, and a diluted EPS loss of $5.20, which dramatically missed estimates of a loss of $2.07. Key growth…

Read full summary

WW International reported Q1 2026 results with revenue of $168.3 million, down 9.6% from $185.2 million year-over-year, and a diluted EPS loss of $5.20, which dramatically missed estimates of a loss of $2.07. Key growth in Clinical Subscription Revenue (+31.8% YOY) was overshadowed by significant declines in Behavioral Revenue (-17.5% YOY), amid ongoing difficulties in subscriber growth and operational efficiency challenges.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

72% Gross margin Operating margin Aug 2023 May 2026

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

From revenue to operating profit

Where each $100 of revenue went in this report.

Of every $100 of revenue Cost of sales $29 Operating expenses $89 Left as operating profit $-18

Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Mar 2023 May 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

Reported figures

Earnings per share
$-5.2

What stood out

  • Revenue Decline

    Q1 2026 revenue was $168.3 million, down 9.6% from $186.6 million in Q1 2025.

  • Clinical Revenue Growth

    Clinical Subscription Revenue rose 31.8%, from $29.5 million in Q1 2025 to $38.8 million in Q1 2026.

  • Increased Marketing Expenses

    Marketing expenses surged to $92.9 million in Q1 2026, compared to $78.8 million in Q1 2025.

  • Interest Expense Reduction

    Interest expense decreased to $11.5 million in Q1 2026, down from $27.6 million in Q1 2025.

  • Decline in Subscribers

    End of Period Subscribers fell by 22.6% from 3,434.1K in Q1 2025 to 2,659.2K in Q1 2026.

  • Gross Margin Decrease

    Gross margin fell to 70.5% in Q1 2026 from 71.2% in Q1 2025.

What to watch

  • Significant Net Loss

    Net loss for Q1 2026 was $52.0 million, compared to $72.6 million in Q1 2025, indicating ongoing financial distress.

  • Subscriber Decline

    Total subscribers decreased by 17.2%, from 3,335.7K in Q1 2025 to 2,760.8K in Q1 2026, impacting profitability.

  • Technology Risks

    Operational reliance on technology raises risks of service disruptions affecting future revenue and brand perception.

Management's outlook

Reaffirms financial guidance for FY 2026, projecting revenue between $620 million and $635 million.

Earlier filings 4

10-K · March 16, 2026

WW positions itself as the integrated destination for weight management in the GLP-1 era, combining its six-decade community/behavioral platform with a U.S. clinical offering that provides access to GLP-1 medications.…

10-Q · November 6, 2025

WW reported revenues of $172,091,000 in the three months ended September 30, 2025, down $20,796,000 (10.8%) versus $192,887,000 in the prior-year quarter, but delivered a positive operating income of $8,035,000 versus…

10-Q · August 1, 2024

WW reported quarterly revenue of $202,073,000 and diluted EPS of $0.29 for the three months ended June 29, 2024. Gross margin expanded to 67.9% and the company returned to operating income of $35,933,000 in Q2, although…

10-Q · May 2, 2024

WW reported net revenue of $206,548,000 for the three months ended March 30, 2024 and a net loss of $347,902,000 (diluted loss per share $4.39). Gross profit expanded to $137,800,000 (66.7% gross margin), but the…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.